Pertussis resurgence: diagnosis, treatment, prevention, and beyond (Q36693838)

15 August 2017

1 reference

title

Pertussis resurgence: diagnosis, treatment, prevention, and beyond (English)

1 reference

15 August 2017

Sarah E Raguckas

1

1 reference

15 August 2017

Heather L VandenBussche

series ordinal

2

1 reference

15 August 2017

Carrie Jacobs

series ordinal

3

1 reference

15 August 2017

Michael E Klepser

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

27

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

41-52

1 reference

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Trends in pertussis among infants in the United States, 1980-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Health burden of pertussis in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Health burden of pertussis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Morbidity of pertussis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Diagnosis and management of pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Encephalopathy after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Economic burden of pertussis and the impact of immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Potential strategies to reduce the burden of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Use of antibiotics in the prevention and treatment of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

Pertussis Immunization of Adolescents in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.41

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.1.41

1 reference

15 August 2017

1 reference